Croda Receives Two EXCiPACT Certifications - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Croda Receives Two EXCiPACT Certifications

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 3
Croda, a global supplier of specialty ingredients, reports it has received two achievements in relation to EXCiPACT, the voluntary system that reduces the audit burden in the pharmaceutical industry by providing independent third-party certification of manufacturers, suppliers, and distributors of excipients.

Croda’s first EXCiPACT certification covers ingredients manufactured at Rawcliffe Bridge in the UK. This achievement is part of a global program to gain accreditation at the six Croda sites that supply pharmaceutical excipients. In addition, the company reports that Croda’s Head of Global Quality Assurance, Iain Moore, was singled out for driving EXCiPACT forward in a speech by Frank Milek, Chair of The International Pharmaceutical Excipients Council Europe at their annual seminar in Cannes.

Source: Croda

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
22%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
37%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here